DE936592C - Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants - Google Patents
Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plantsInfo
- Publication number
- DE936592C DE936592C DEP12946A DEP0012946A DE936592C DE 936592 C DE936592 C DE 936592C DE P12946 A DEP12946 A DE P12946A DE P0012946 A DEP0012946 A DE P0012946A DE 936592 C DE936592 C DE 936592C
- Authority
- DE
- Germany
- Prior art keywords
- trioxyflavone
- blood
- glucoside
- plants
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Description
Verfahren zur Herstellung eines blut- und harnzuckersenkenden Präparates aus trioxyflavonglukosidhaltigen Pflanzenteilen Es ist bereits bekannt, daß durch perorale Gaben pflanzlicher Totalextraktivstoffe, z.B. Bohnen schalen, Beeinflussungen der Blutzuckerwerte ansgelöst werden können.Process for the production of a blood and urine lowering preparation from plant parts containing trioxyflavone glucoside It is already known that by oral administration of total plant extracts, e.g. bean shells, influences the blood sugar levels can be dissolved.
Die vorliegende Erfindung bezieht sich nun auf ein Verfahren zur Herstellung therapeutisch wirksamer, mit dreiwertigen seltenen Erden substituierter Trioxyflavone, die, wie im Tierexperiment mit alloxandiabetischen Ratten festgestellt wurde, insbesondere einen spezifisch blut- und harnzuckersenkenden Effekt ausüben. The present invention now relates to a method for Production of therapeutically effective substitutes with trivalent rare earths Trioxyflavone, which, as found in animal experiments with alloxandiabetic rats in particular have a specific blood- and urine-lowering effect.
Es wurde gefunden, daß man derartige Substanzen gewinnen kann, wenn man trioxyflavonglukosidhaltige Pflanzenteile, z. B. Flores Chamomillale, zur nächst einer Chloroformextraktion, anschließend einer Extraktion und Umkristallisation aus Äther unterzieht und die gewonnenen Trioxyflavone schließlich an dreiwertige seltene Erden nach Fr i edel - C rafts in Form einer Substitutionsbindung anlagert. Als besonders vorteilhaft erwiesen sich für d.ie Anlagerungen in bezug auf technische Durchführung und Ausbeute die Chloride des Cers und Praseodyms. Die auf diese Weise hergestellten Präparate ermöglichen eine gezielte Therapie auf die beim Diabetes gestörten Stoffwechsel- und enzymatischen Vorgänge sowie auf das Zerrtralnervensystem. It has been found that such substances can be obtained if you trioxyflavonglucosidhaltige parts of plants, z. B. Flores Chamomillale, next a chloroform extraction, then an extraction and recrystallization from ether undergoes and the obtained trioxyflavones finally to trivalent rare earths according to Fri edel - C rafts in the form of a substitution bond. The deposits have proven to be particularly advantageous with regard to technical Execution and yield the chlorides of cerium and praseodymium. The preparations produced in this way enable targeted therapy the metabolic and enzymatic processes disturbed in diabetes as well as the Pulling nerve system.
Der Erfindungsgegenstand wird an folgenden Ausführungsbeispielen erläutert: B e i s p i e l 1 500 g Flores Chamomillae werden im Soxhlet für die Dauer von 5 Stunden einer Extraktion mit Chloroform unterzogen. Die Menge des Chloroforms ist gleich der fünffachen des angewandten Extraktionsgutes. Nach Abdampfen des Chloroforms wird der Rückstand mit der auf das Fünffache berechneten Menge go°/oigen Alkohols aufgenommen und damit einer nochmaligen Extraktion von 3 Stunden unterzogen. The subject matter of the invention is based on the following exemplary embodiments Explanation: Ex ample 1 500 g Flores Chamomillae are used in the Soxhlet for the Subjected to extraction with chloroform for 5 hours. The amount of chloroform is equal to five times the amount of extraction material used. After evaporation of the chloroform the residue with the fivefold calculated amount of go% alcohol added and thus subjected to another extraction of 3 hours.
Nach dem Abdampfen des Alkohols bleibt eine braune, schmierige Masse zurück, die nunmehr einer nochmaligen Extraktion mit der fünffachen Menge, bezogen auf die Ausbeute des Rückstandes, äther für 21/2 Stunden unterzogen wird. Dieser Vorgang wird wiederholt. After the alcohol has evaporated, a brown, greasy mass remains back, which is now based on another extraction with five times the amount on the yield of the residue, ether for 21/2 hours is subjected. This The process is repeated.
Nach dem Abdampfen des Äthers bleibt eine braune, kristallinische Masse zurück. Die Aus beute beträgt etwa 15% des Ausgangsmaterials. After the ether has evaporated, it remains brown, crystalline Mass back. The yield is around 15% of the starting material.
536,46 g dieser so gewonnenen, aus 5, 7, 4,' Trioxyflavon bestehenden Substanz werden mit 246,5 g Cerchlorid in 1 l Wasser gelöst, mit 5 g wasserfreiem Aluminiumchlorid versetzt und dann auf 60 bis 70° erhitzt. Die Umsetzung zu dem Cer-Trioxyflavon vollzieht sich analog der Friedel-Craftsschen Reaktion. 536.46 g of this thus obtained, consisting of 5, 7, 4, 'Trioxyflavon existing Substance are dissolved with 246.5 g of cerium chloride in 1 l of water, with 5 g of anhydrous Added aluminum chloride and then heated to 60 to 70 °. Implementation to that Cerium trioxyflavone takes place analogously to the Friedel-Crafts reaction.
Es bildet sich eine komplexe Verbindung, wobei das Cer als Substituent auftritt. Die so gewonnene Substanz stellt ein hellbräunliches Produkt dac, das mit Alkohol. (700/0) ausgewaschen, abgenutscht und bei 50° im Trockenschrank getrocknet wird. Die Ausbeute beträgt etwa 500 g, das Molekulargewicht der kristallinischen Masse 676,6 und der Schmelzpunkt 108,2° C. A complex compound is formed, with cerium as a substituent occurs. The substance obtained in this way represents a light brownish product which with alcohol. (700/0) washed out, suction filtered and dried at 50 ° in a drying cabinet will. The yield is about 500 g, the molecular weight of the crystalline Mass 676.6 and the melting point 108.2 ° C.
B e i s p i e l 2 Unter den gleichen Herstellungsbedingungen und auch unter Verwendung von- Flores Chamomillae als Ausgangssubstanz wird die komplexe Verbindung an Stelle mit Cerium als Substituenten mit Praseodym durchgeführt. Example 2 Under the same manufacturing conditions and also using Flores Chamomillae as the starting substance becomes the complex Compound carried out in place of cerium as a substituent with praseodymium.
Wesentlich für den, Erfindungsgegenstand ist, daß das gewonnene Trioxyflavon mit dreiwertigen seltenen Erden substituiert wird und mit den so gewonnenen Substanzen überraschende, tierexperimentell bestätigte blut- und harnzuckersenkende Wirkungen erzielt wurden. It is essential for the subject of the invention that the trioxyflavone obtained is substituted with trivalent rare earths and with the substances obtained in this way surprising, animal experiments confirmed blood- and urine-lowering effects were achieved.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP12946A DE936592C (en) | 1954-10-28 | 1954-10-28 | Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP12946A DE936592C (en) | 1954-10-28 | 1954-10-28 | Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants |
Publications (1)
Publication Number | Publication Date |
---|---|
DE936592C true DE936592C (en) | 1956-01-12 |
Family
ID=7364348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DEP12946A Expired DE936592C (en) | 1954-10-28 | 1954-10-28 | Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE936592C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0096016A2 (en) * | 1982-06-02 | 1983-12-07 | BONOMELLI S.p.A. | Therapeutic composition having an antibacterial action and made from a fraction extracted from camomile flower, and the process for the preparation of this fraction |
-
1954
- 1954-10-28 DE DEP12946A patent/DE936592C/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0096016A2 (en) * | 1982-06-02 | 1983-12-07 | BONOMELLI S.p.A. | Therapeutic composition having an antibacterial action and made from a fraction extracted from camomile flower, and the process for the preparation of this fraction |
EP0096016A3 (en) * | 1982-06-02 | 1984-03-21 | Bonomelli S.P.A. | Therapeutic composition having an antibacterial action and made from a fraction extracted from camomile flower, and the process for the preparation of this fraction |
US4584198A (en) * | 1982-06-02 | 1986-04-22 | Bonomelli S.P.A. | Therapeutic compositions having antibacteric activity comprising a fraction extracted from camomile flowers and process for the preparation of said fraction |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2656602C3 (en) | Method for extracting 2-hydroxymethyl-3,4,5-trihydroxypiperidine from mulberry plants | |
DE936592C (en) | Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants | |
DE2735455B2 (en) | Daunomycin analogs, processes for their preparation and pharmaceuticals containing these compounds | |
DE1468554C (en) | 20 beta tert amino 3 alpha hydroxy (or acyloxy) 5 beta pregnane or its salts and processes for their manufacture | |
AT202712B (en) | Process for the extraction of alkaloids | |
DE1212542B (en) | Process for the preparation of water-soluble diethyl acetals from xanthine derivatives | |
DE864312C (en) | Process for the production of crystallized cardiac glycosides, such as. B. Convallatoxin and Digitoxin | |
DE1593807C (en) | alpha ascine methyl or ethy (ester, as well as a process for their production | |
DE856739C (en) | Process for the synthetic production of adenosine-5-triphosphoric acid | |
DE1568924C (en) | Proscillaridine ketals and process for their preparation | |
DE1963318C (en) | Silybin half ester of silybin with 1 and or or 2 mol of succinic acid and its salts with pharmacologically acceptable inorganic or organic bases, and drugs | |
DE958924C (en) | Process for the preparation of mercury-containing dioxypropane compounds | |
DE1468554B1 (en) | 20beta-tert-amino-3alpha-hydroxy- (or-acyloxy) -5beta-pregnanes or their salts and processes for their preparation | |
CH338837A (en) | Process for the preparation of deserpidic acid or its salts | |
DE1029825B (en) | Process for the preparation of 19-nortestosterone hexahydrobenzoate | |
DE1016267B (en) | Process for the preparation of N-methylol-N-methyl-2-mercaptoimidazole | |
DE2139124B2 (en) | Process for obtaining tetracycline | |
DE1618265A1 (en) | Process for the production of new bile acid derivatives | |
DE1101415B (en) | Process for the preparation of 6ª ‡ -Methyl-17ª ‡ -acetoxy-4-pregnen-3, 20-dione | |
DE1044820B (en) | Process for the preparation of reserpoxidic acid monoesters with free hydroxyl group and their salts | |
CH482667A (en) | Process for the preparation of rutin derivatives | |
DE1020155B (en) | Process for the extraction of new glucosides from Podophyllum species | |
DE1050506B (en) | Process for the production of an active ingredient concentrate from senna drugs | |
DE1291336B (en) | Process for the preparation of 3ª ‡ - (N, N-dimethylaminoacetoxy) -11-oxo-20, 20-bis- (nitratomethyl) -21-nitrato-5ª ‰ -pregnane and acid addition salts thereof | |
CH210725A (en) | Process for the preparation of a monoester of the androstene series. |